Singapore markets closed
Straits Times Index
3,300.04 -3.15 (-0.10%) S&P 500
5,180.74 +52.95 (+1.03%) Dow
38,852.27 +176.59 (+0.46%) Nasdaq
16,349.25 +192.92 (+1.19%) Bitcoin USD
63,702.89 +208.95 (+0.33%) CMC Crypto 200
1,318.79 -46.34 (-3.39%)
Kodiak Sciences Inc. (KOD)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 3.7700 |
| Open | 3.8200 |
| Bid | 3.9300 x 400 |
| Ask | 3.9700 x 200 |
| Day's range | 3.7536 - 4.0500 |
| 52-week range | 1.3700 - 9.8000 |
| Volume | |
| Avg. volume | 795,098 |
| Market cap | 206.988M |
| Beta (5Y monthly) | 2.13 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Will Kodiak Sciences (NASDAQ:KOD) Spend Its Cash Wisely?
We can readily understand why investors are attracted to unprofitable companies. For example, although...
- Zacks
Kodiak (KOD) Counts on Tarcocimab Program Despite Setbacks
Kodiak (KOD) initiates a phase III study evaluating tarcocimab in diabetic retinopathy, which is expected to serve as the basis for a regulatory filing for three eye disease indications.
- Insider Monkey
Kodiak Sciences Inc. (NASDAQ:KOD) Q4 2023 Earnings Call Transcript
Kodiak Sciences Inc. (NASDAQ:KOD) Q4 2023 Earnings Call Transcript March 28, 2024 Kodiak Sciences Inc. misses on earnings expectations. Reported EPS is $-1.13 EPS, expectations were $-0.86. Kodiak Sciences Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
© 2024 Yahoo. All rights reserved.